LEXINGTON, Mass. and SINGAPORE, June 4, 2025 /PRNewswire/ -- Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T therapies for solid tumors, today ...
SHANGHAI and NEW YORK, June 10, 2025 /PRNewswire/ -- Sanyou Biopharmaceuticals, a leading Shanghai-based high-tech biopharmaceutical company specializing in biologics R&D today announced the signing ...
Seoul National University College of Engineering announced that a research team led by Professor Sunghoon Kwon from the Department of Electrical and Computer Engineering, in collaboration with ...
Day One Biopharmaceuticals has announced the appointment of Dr. Michael Vasconcelles as Head of Research & Development, bringing over 25 years of experience in oncology research and corporate ...
Paradigm Biopharmaceuticals (ASX: PAR) has entered into a binding term sheet with AVet Health to co-develop and license a ...
NEW YORK and SHANGHAI, June 09, 2025 (GLOBE NEWSWIRE) -- Medicovestor, Inc., a New York-based biotechnology company pioneering first-in-class chemoimmunotherapy antibody-drug conjugates (ADCs) today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results